These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 9769948

  • 1. [Germline mutations of the p53 gene].
    Frebourg T.
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [Abstract] [Full Text] [Related]

  • 2. [Li-Fraumeni syndrome].
    Frebourg T.
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [Abstract] [Full Text] [Related]

  • 3. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P.
    Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995
    [Abstract] [Full Text] [Related]

  • 4. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun 08; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 5. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN.
    J Clin Oncol; 2009 Mar 10; 27(8):1250-6. PubMed ID: 19204208
    [Abstract] [Full Text] [Related]

  • 6. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
    Frebourg T, Abel A, Bonaiti-Pellie C, Brugières L, Berthet P, Bressac-de Paillerets B, Chevrier A, Chompret A, Cohen-Haguenauer O, Delattre O, Feingold J, Feunteun J, Frappaz D, Fricker JP, Gesta P, Jonveaux P, Kalifa C, Lasset C, Leheup B, Limacher JM, Longy M, Nogues C, Oppenheim D, Sommelet D, Soubrier F, Stoll C, Stoppa-Lyonnet D, Tristant H.
    Bull Cancer; 2001 Jun 10; 88(6):581-7. PubMed ID: 11459705
    [Abstract] [Full Text] [Related]

  • 7. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM.
    Oncogene; 1998 Sep 03; 17(9):1061-8. PubMed ID: 9764816
    [Abstract] [Full Text] [Related]

  • 8. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G.
    Cell Growth Differ; 1992 Nov 03; 3(11):839-46. PubMed ID: 1467311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G.
    Oncogene; 1994 Nov 03; 9(11):3273-80. PubMed ID: 7936651
    [Abstract] [Full Text] [Related]

  • 13. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC, Lozano G.
    Mol Med Today; 1997 Sep 03; 3(9):390-5. PubMed ID: 9302689
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
    Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM.
    Oncogene; 2001 Aug 02; 20(34):4621-8. PubMed ID: 11498785
    [Abstract] [Full Text] [Related]

  • 16. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
    Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J.
    N Engl J Med; 1992 May 14; 326(20):1309-15. PubMed ID: 1565144
    [Abstract] [Full Text] [Related]

  • 17. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T, Soussi T.
    Arch Pediatr; 1994 Jan 14; 1(1):61-70. PubMed ID: 8087224
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C, Voigtländer T, Lübbert M.
    J Cancer Res Clin Oncol; 2002 Aug 14; 128(8):456-60. PubMed ID: 12200603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.